Ask Warren

Poongjeon Pharmacy

298060 · KOSDAQ · ₩298060 · 풍전약품

₩2,350▼ ₩25 (1.05%)End-of-day · Oct 30, 2026 · End-of-day prices.
Trade
Alert me
SellBuy
AnnualQuarterly

Income statement

Q2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024
Revenue₩23B₩4.1B₩2.1B₩320M₩639M₩574M₩160M₩170M
Cost of sales₩19B₩886M₩668M₩121M₩471M₩371M₩98M₩77M
Gross profit₩3.8B₩3.2B₩1.4B₩199M₩168M₩203M₩63M₩93M
Operating income−₩841M−₩1.6B−₩1.1B−₩1.1B−₩903M−₩1.5B−₩2.8B−₩3B
Net income−₩2B−₩1.9B−₩637M−₩1.1B₩1.5B−₩1.5B−₩9.3B−₩350M
Net income to shareholders−₩2B−₩1.9B−₩637M−₩1.1B₩1.5B−₩1.5B−₩9.3B−₩350M

Balance sheet

Q2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024
Total assets₩48B₩41B₩42B₩34B₩28B₩29B₩23B₩19B
Current assets₩30B₩11B₩13B₩5.1B₩13B₩4.3B₩2B₩3.6B
Cash and equivalents₩4.8B₩74M₩6.5B₩3.2B₩157M₩114M₩50M₩163M
Total liabilities₩16B₩8.5B₩8.3B₩6B₩4.1B₩8.7B₩9B₩7.1B
Current liabilities₩13B₩6.4B₩6B₩931M₩1.9B₩5.5B₩5.7B₩2.9B
Borrowings₩3.8B₩2.7B₩2.5B₩2.5B—₩6.8B₩6.8B₩3.6B
Total equity₩32B₩32B₩34B₩28B₩24B₩21B₩14B₩12B
Shareholders' equity₩32B₩32B₩34B₩28B₩24B₩21B₩14B₩12B

Cash flow

Q2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024
Cash from operations−₩3.1B−₩839M−₩1.2B−₩129M−₩1.4B−₩2B−₩2B−₩3B
Capital spending₩34M₩0₩201M₩248M₩14M₩4.1B₩2.3B₩1.7B
Free cash flow−₩3.1B−₩839M−₩1.4B−₩377M−₩1.4B−₩6.1B−₩4.3B−₩4.7B

Consolidated where available. Amounts in won.

Also known as: Poongjeon Pharmacy / 풍전약품 / 298060 / KRX:298060

Source: KRX statistical information